These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6254633)

  • 1. Esters of phosphonopropionic and phosphonoacetic acids: effect on synthesis of Epstein-Barr virus (EBV) antigens and on transformation of cord blood lymphocytes by EBV.
    Margalith M; Manor D; Agranat I; Bentor Y; Gelfand T; Goldblum N
    Cancer Biochem Biophys; 1980; 4(3):137-43. PubMed ID: 6254633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organophosphorous compounds as inhibitors of EBV infection and transformation.
    Margalith M; Manor D; Goldblum N
    Dev Biol Stand; 1982; 52():515-26. PubMed ID: 6299860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphonoacetic acid: inhibition of transformation of human cord blood lymphocytes by Epstein-Barr virus.
    Manor D; Margalith M
    Cancer Biochem Biophys; 1979; 3(4):157-62. PubMed ID: 233303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytofluorometry of lymphocytes infected with Epstein-Barr virus: effect of phosphonoacetic acid on nucleic acid.
    Lemon SM; Hutt LM; Pagano JS
    J Virol; 1978 Jan; 25(1):138-45. PubMed ID: 202732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphonoformate inhibits synthesis of Epstein-Barr virus (EBV) capsid antigen and transformation of human cord blood lymphocytes by EBV.
    Margalith M; Manor D; Usieli V; Goldblum N
    Virology; 1980 Apr; 102(1):226-30. PubMed ID: 6245504
    [No Abstract]   [Full Text] [Related]  

  • 6. On the continuous culturing of B.95-8 cells in the presence of phosphonoacetic acid.
    Margalith M; Manor D; Goldblum N
    J Virol Methods; 1980; 1(6):349-54. PubMed ID: 6262340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid and steroids inhibit Epstein-Barr virus-induced nuclear antigen, DNA synthesis and lymphocyte transformation.
    Sundar SK; Levine PH; Ablashi DV; Menezes J
    Anticancer Res; 1984; 4(6):415-8. PubMed ID: 6097161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of Epstein-Barr virus antigens and DNA-polymerase activities in P3HR-1 cell line and its subline passaged in the presence of phosphonoformate.
    Prachová K; Roubal J; Vonka V; Brichácek B; Reifová M
    Acta Virol; 1983 Jul; 27(4):329-36. PubMed ID: 6138996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity of arabinofuranosyladenine and erythro-9-(2-hydroxy-3-nonyl) adenine to Epstein-Barr virus producer and nonproducer lymphoma cells in culture.
    Margalith M; Manor D; Cohen T
    Cancer Biochem Biophys; 1983; 6(3):189-96. PubMed ID: 6303555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on transformation of human lymphocytes by Epstein-Barr virus (author's transl)].
    Takada K
    Hokkaido Igaku Zasshi; 1980 Sep; 55(5):447-70. PubMed ID: 6263773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of the transforming and replicative functions of Epstein--Barr virus to inhibition by phosphonoacetate.
    Rickinson AB; Epstein MA
    J Gen Virol; 1978 Aug; 40(2):409-20. PubMed ID: 211188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
    Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP
    J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation of rabbit lymphocytes by an Epstein-Barr virus-related herpesvirus from Macaca arctoides.
    Meerbach A; Friedrichs C; Thust R; Wutzler P
    Arch Virol; 2004 Jun; 149(6):1083-94. PubMed ID: 15168196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of DNA synthesis inhibitors on early antigen expression following primary infection or superinfection by Epstein-Barr virus.
    Lidin BI; Lamon EW
    Arch Virol; 1983; 77(1):13-25. PubMed ID: 6312934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by phosphonoacetate of the in vitro outgrowth of Epstein-Barr virus genome-containing cell lines from the blood of infectious mononucleosis patients.
    Rickinson AB; Finerty S; Epstein MA
    IARC Sci Publ (1971); 1978; (24 Pt 2):721-8. PubMed ID: 221394
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro transforming activity of Epstein-Barr virus (EBV). II. Differences between M81 and B95-8 EBV strains.
    Desgranges C; Lavoué MF; Patet J; de-Thé G
    Biomedicine; 1979 Jun; 30(2):102-8. PubMed ID: 224964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of selenium-rich rice on transformation of umbilical blood B lymphocytes by Epstein-Barr virus and Epstein-Barr virus early antigen expression].
    Jian SW; Mei CE; Liang YN; Li D; Chen QL; Luo HL; Li YQ; Cai TY
    Ai Zheng; 2003 Jan; 22(1):26-9. PubMed ID: 12561431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
    AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of Epstein-Barr virus derived from a nasopharyngeal carcinoma that has transforming and lytic properties.
    Sato H; Takimoto T; Ogura H; Tanaka J; Hatano M; Glaser R
    J Natl Cancer Inst; 1986 Jun; 76(6):1019-24. PubMed ID: 3012175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid.
    Summers WC; Klein G
    J Virol; 1976 Apr; 18(1):151-5. PubMed ID: 176457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.